Weekly News Recap #Phispers
Trump withdraws US from WHO; Novo’s Ozempic, Wegovy among 15 new drugs chosen for price negotiations under IRA
On the day Donald Trump was sworn in as the 47th President of the United States, there was a deluge of some 200 measures, which...
Impressions : 1889
Astra faces probe in China; AbbVie, EvolveImmune ink potential US$ 1.4 bn deal; EC levies US$ 503 mn fine on Teva
In this week’s Phispers, AstraZeneca faces a major crisis in China as its president Leon Wang is under investigation in w...
Impressions : 1152
China to work with EU on aligning API standards; Lupin stumbles with FDA yet again
This week, Phispers has news from China, where its drug regulator said it would work with European Commission’s drug regu...
Impressions : 2229
FDA releases GDUFA II fee for FY20; Teva to recover settlement charge from execs
This week, the USFDA released its GDUFA II user fee for fiscal 2020.
Unlike last year, when the fees were hiked significantly...
Impressions : 1680
Japan approves drug that cures flu in as soon as 24 hours; Teva repositions brand, shuts offices in US
This week Phispers covers Xofluza, a drug approved in Japan that kills the influenza virus in 24 hours. It is poised to give Ro...
Impressions : 4464
FDA seeks changes in 180-day exclusivity for generics; Data-integrity concerns at Bayer`s German facility
This week, Phispers brings you news on the FY 2019 budget proposals in the US that seek to change the way generic drugs come to...
Impressions : 3762

